TABLE 1

Baseline characteristics of included patients

VariableOverallSymptomsp-value
≤14days>14days
Patients n6123335 patients missing
Studies n7632386 studies missing
Age years66 (59–73)69 (60–76)65 (59–73)0.18
Male55 (90)21 (91)30 (91)1
BMI m·kg−228.5±4.928.1±4.928.6±5.20.75
Mechanically ventilated58 (95)21 (98)32 (97)0.29
Controlled ventilator mode35 (58)15 (65)15 (45)0.11
NMBA use18 (30)7 (30)8 (24)0.84
Days until LUS
 Symptoms15 (11–21)11 (9–13)20 (17–25)N/A
 Hospital admission7 (4–13)5 (3–6)13 (7–17)0.00
 ICU admission3 (1–12)2 (1–3)10 (3–19)0.00
 Mechanical ventilation4 (2–11)3 (1–4)10 (3–15)0.00
Ventilator settings
FIO2 %50 (40–60)55 (47–60)50 (40–60)0.49
 Pressure above PEEP cmH2O12 (10–15)13 (10–15)11 (5–17)0.17
 PEEP cmH2O12±312±411±30.05
Arterial blood gas
 pH7.38 (7.33–7.45)7.37 (7.31–7.44)7.41 (7.34–7.45)0.19
PaCO2 kPa6.6 (5.7–7.5)6.2 (5.6–7.2)6.7 (5.9–7.6)0.31
PaO2 kPa9.7±1.39.8±1.49.6±1.20.55
 P/F ratio mmHg147±42145±42148±400.95
Other
 SOFA8 (7–10)8 (7–10)9 (7–11)0.16
 Respiratory rate24±523±425±50.13
 Systolic blood pressure mmHg119 (106–132)117 (106–129)119 (107–138)0.71
 Diastolic blood pressure mmHg56 (51–63)55 (51–62)55 (50–64)0.85
 WBC ×109 cells·L−110.4 (6.6–15.2)8.7 (5.2–12.3)13.8 (7.8–17.7)0.01
 CRP mg·L−1204±109216±100187±1020.20
 Creatinine umol·L−196 (70–164)96 (70–150)99 (70–168)0.80
 Fluid balance since admission mL245 (−492–1027)344 (−442–835)215 (−904–1224)0.80

Data are presented as median (interquartile range), n (%) or mean±sd, unless otherwise stated. BMI: body mass index; NMBA: neuromuscular blockade; LUS: lung ultrasound score; ICU: intensive care unit; FIO2: inspiratory oxygen fraction; PEEP: positive end-expiratory pressure; PaCO2: arterial carbon dioxide tension; PaO2: arterial oxygen tension; P/F: PaO2/FIO2; SOFA: sequential organ failure assessment; WBC: white blood cell; CRP: C-reactive protein; N/A: not available.